Literature DB >> 18156043

Chordoma of the spinal column.

Daniel M Sciubba1, John H Chi, Laurence D Rhines, Ziya L Gokaslan.   

Abstract

Chordomas are the most common primary malignant tumor of the mobile spine and of the sacrum. Although considered not to possess significant metastatic potential, such lesions are locally aggressive, leading to neurologic compromise and lytic destruction of bone. En bloc resection has afforded patients the greatest chance of local control and disease-free survival. Such radical resections may be associated with significant surgical morbidity, however. Although considered generally resistant to radiation therapy and chemotherapy, recent advances in photon and proton radiation therapy and use of monoclonal antibodies may provide improved outcomes for poor surgical candidates and for tumors that recur after surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18156043     DOI: 10.1016/j.nec.2007.09.006

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  33 in total

Review 1.  Notochord to Nucleus Pulposus Transition.

Authors:  Lisa Lawson; Brian D Harfe
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

2.  [Cervical paravertebral lesion].

Authors:  M Lehmann; D Korbmacher; U Hamberger; H Sudhoff
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

3.  MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.

Authors:  Eiji Osaka; Xiaoqian Yang; Jacson K Shen; Pei Yang; Yong Feng; Henry J Mankin; Francis J Hornicek; Zhenfeng Duan
Journal:  J Orthop Res       Date:  2014-04-24       Impact factor: 3.494

4.  Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.

Authors:  Isaac O Karikari; Christopher L Gilchrist; Liufang Jing; David A Alcorta; Jun Chen; William J Richardson; Mostafa A Gabr; Richard D Bell; Michael J Kelley; Carlos A Bagley; Lori A Setton
Journal:  J Neurosurg Spine       Date:  2014-06-06

5.  Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma.

Authors:  Matthew T Houdek; Peter S Rose; Mario Hevesi; Joseph H Schwab; Anthony M Griffin; John H Healey; Ivy A Petersen; Thomas F DeLaney; Peter W Chung; Michael J Yaszemski; Jay S Wunder; Francis J Hornicek; Patrick J Boland; Franklin H Sim; Peter C Ferguson
Journal:  J Surg Oncol       Date:  2019-02-07       Impact factor: 3.454

Review 6.  Variables affecting functional improvement in chordoma patients admitted to an inpatient rehabilitation facility: A retrospective review.

Authors:  Sasha E Knowlton; Richard Goldstein; Kevin C O'Connor; Joseph Schwab; Francis Hornicek; Ross Zafonte
Journal:  J Spinal Cord Med       Date:  2017-05-02       Impact factor: 1.985

7.  Characterization and analysis of human chordoma cell lines.

Authors:  Cao Yang; Francis J Hornicek; Kirkham B Wood; Joseph H Schwab; Edwin Choy; John Iafrate; Andrew Rosenberg; G Petur Nielsen; Ramnik J Xavier; Henry Mankin; Zhenfeng Duan
Journal:  Spine (Phila Pa 1976)       Date:  2010-06-01       Impact factor: 3.468

Review 8.  Cryosurgery in the excision of a giant local recurrent sacral chordoma: a case report and literature review.

Authors:  Valerio Pipola; Marco Girolami; Riccardo Ghermandi; Giuseppe Tedesco; Gisberto Evangelisti; Alessandro Gasbarrini
Journal:  Eur Spine J       Date:  2018-01-25       Impact factor: 3.134

Review 9.  Epigenetic deregulations in chordoma.

Authors:  Xin Yu; Zheng Li
Journal:  Cell Prolif       Date:  2015-08-10       Impact factor: 6.831

10.  Single-Fraction Spine Stereotactic Body Radiation Therapy for the Treatment of Chordoma.

Authors:  Edward W Jung; David L Jung; Ehsan H Balagamwala; Lilyana Angelov; John H Suh; Toufik Djemil; Anthony Magnelli; Samuel T Chao
Journal:  Technol Cancer Res Treat       Date:  2016-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.